Iqvia's Q2 Solutions opens new lab

By The Science Advisory Board staff writers

October 6, 2021 -- Iqvia announced the opening of a 160,000-sq-ft lab for its subsidiary, Q2 Solutions.

The facility will include bioanalytical, vaccine, biomarker, and genomics labs. The custom-designed laboratory spaces will be known as Q2 Solutions Innovation Laboratories and are located at the Iqvia Innovation Park Campus in North Carolina.

Through a collaboration with the North Carolina Department of Commerce and the Economic Development Partnership of North Carolina, Iqvia expects the new facility to create 750 new jobs over the next 10 years.

Iqvia partners with Healthcore
Iqvia is partnering with Healthcore to advance real-world evidence studies that offer better quality and increased efficiency.
Iqvia enhances its medical contact center services
Iqvia has added new artificial intelligence-powered technologies to enhance its existing medical information contact center services.
Iqvia debuts clinical data analytics suite
Iqvia has debuted its Clinical Data Analytics Suite, a new software as a service-based clinical data analytics platform.
Iqvia debuts clinical data analytics intelligence platform
Iqvia has debuted a clinical data analytics intelligence platform to accelerate vaccine development and drug discovery.

Copyright © 2021

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter